Unichem Laboratories (NSE:UNICHEMLAB) Other Long-Term Liabilities: ₹403 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
74 GF Score
Price ₹489.75
GF Value ₹686.21
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories Other Long-Term Liabilities?

Unichem Laboratories NSE:UNICHEMLAB -1.54% 74 Other Long-Term Liabilities is ₹403 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 74/100 and a GF Value™ of ₹686.21 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Unichem Laboratories's other long-term liabilities for the quarter that ended in Mar. 2026 was ₹403 Mil.

Unichem Laboratories's quarterly other long-term liabilities declined from Sep. 2025 (₹376 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹403 Mil).

Unichem Laboratories's annual other long-term liabilities increased from Mar. 2024 (₹9 Mil) to Mar. 2025 (₹30 Mil) and increased from Mar. 2025 (₹30 Mil) to Mar. 2026 (₹403 Mil).

Unichem Laboratories Other Long-Term Liabilities Related Terms

Unichem Laboratories Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Other Long-Term Liabilities Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.92 10.95 8.70 29.80 403.00

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.80 0.00 376.50 0.00 403.00
NSE:UNICHEMLAB
74GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of ₹403 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Other Long-Term Liabilities of ₹403 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Unichem Laboratories and its competitors.
Is Unichem Laboratories' Other Long-Term Liabilities too high?
Unichem Laboratories' current Other Long-Term Liabilities is ₹403 Mil. Overall, Unichem Laboratories has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Other Long-Term Liabilities compare to ZTS?
Unichem Laboratories' Other Long-Term Liabilities of ₹403 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Unichem Laboratories and its competitors. Unichem Laboratories's current Other Long-Term Liabilities is ₹403 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹686.21, compared to a current price of ₹489.75 — trading 28.6% below its estimated fair value. The current Other Long-Term Liabilities is ₹403 Mil. Unichem Laboratories' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Other Long-Term Liabilities is ₹403 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹489.75 is trading 28.6% below its estimated GF Value™ of ₹686.21. GuruFocus considers Unichem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Other Long-Term Liabilities: ₹403 Mil
  • GF Value™: ₹686.21 vs. price of ₹489.75 (28.6% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
74GF Score

Get the complete analysis for NSE:UNICHEMLAB

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹489.75
Price
₹686.21
GF Value